Browse By: Country ι Category ι Tag

Bladder Cancer Market Research Reports

Global Bladder Cancer Partnering 2010 to 2017
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation o
Published Date: Feb 2017
Published By: Current Partnering

Price: $1495
Gallbladder Cancer-Pipeline Insights, 2017
DelveInsight’s, “ Gallbladder Cancer-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Gallbladder Cancer. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Gallbladder Cancer. DelveInsight’s Report also assesses the Gallbladder Cancer the
Published Date: Jan 2017
Published By: DelveInsight

Price: $1250
Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2017
DelveInsight’s, “ Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Non Muscle Invasive Bladder Cancer (NMIBC). The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Non Muscle Invasive Bladder Cancer (NMIB
Published Date: Jan 2017
Published By: DelveInsight

Price: $1250
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2017
DelveInsight’s, “ Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer). The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive o
Published Date: Jan 2017
Published By: DelveInsight

Price: $1250
Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
DelveInsight’s Report, “Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Bladder Cancer Report is to understand the market and pipeline status of the drugs around the Bladder Cancer to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Bladder Cancer. While the leading brands,
Published Date: Jan 2017
Published By: DelveInsight

Price: $2000
Bladder cancer- Market Insights, Epidemiology and Market Forecast-2023
Note*: This report requires 5-7 business days to complete. DelveInsight’s Bladder cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Bladder cancer forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Bladder cancer till 2023. Key Coverage and Benefits • The report will help in developing business strategies by understanding the trends shaping and driving the global Bladder cancer market. •
Published Date: Jan 2017
Published By: DelveInsight

Price: $4950
Gallbladder Cancer - Market Insights, Epidemiology and Market Forecast-2023
DelveInsight’s Gallbladder Cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Gallbladder Cancer forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Gallbladder Cancer till 2023. Key Coverage and Benefits • The report will help in developing business strategies by understanding the trends shaping and driving the global Gallbladder Cancer market. • Identifying patient populations in t
Published Date: Jan 2017
Published By: DelveInsight

Price: $4950
Bladder cancer- Epidemiology Forecast To 2023
Please note: This report requires 5-7 business days to complete. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication. Scope of the Report • The Report includes the prevalent population and how will it change over the next eight years. • Prevalent or incident cases segmented by age and sex. • Coverage of key Bladder cancer subpopulations and its prevalent or incident cases • The key differences in epidemiology patterns across the seven market segments Key Coverage and Benefits • The report will help in developing business strategies by understanding the trends shaping and driving the global Bladder cancer market. • Identifying prevalent patient populations as well as risk factors in the global Blad
Published Date: Jan 2017
Published By: DelveInsight

Price: $2750
Gallbladder Cancer - Epidemiology Forecast To 2023
Please note: This report requires 5-7 business days to complete. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication. Scope of the Report • The Report includes the prevalent population and how will it change over the next eight years. • Prevalent or incident cases segmented by age and sex. • Coverage of key Gallbladder Cancer  subpopulations and its prevalent or incident cases • The key differences in epidemiology patterns across the seven market segments Key Coverage and Benefits • The report will help in developing business strategies by understanding the trends shaping and driving the global Gallbladder Cancer  market. • Identifying prevalent patient populations as well as risk factors in the
Published Date: Jan 2017
Published By: DelveInsight

Price: $2750
Global Superficial Bladder Cancer Drugs Market Research Report 2016
Production, means the output of Superficial Bladder Cancer Drugs Revenue, means the sales value of Superficial Bladder Cancer Drugs This report studies Superficial Bladder Cancer Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering Altor BioScience Corporation APIM Therapeutics AS Bavarian Nordic A/S Cold Genesys, Inc. Spectrum Pharmaceuticals, Inc. Telesta Therapeutics Inc. UroGen Pharmaceuticals, Ltd. Viventia Bio Inc. endo pharmaceutical SANOFI Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Superficial Bladder Ca
Published Date: Dec 2016
Published By: QYResearch

Price: $2900
Global Superficial Bladder Cancer Drugs Market Professional Survey Report 2016
Production, means the output of Superficial Bladder Cancer Drugs Revenue, means the sales value of Superficial Bladder Cancer Drugs This report studies Superficial Bladder Cancer Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Altor BioScience Corporation APIM Therapeutics AS Bavarian Nordic A/S Cold Genesys, Inc. Spectrum Pharmaceuticals, Inc. Telesta Therapeutics Inc. UroGen Pharmaceuticals, Ltd. Viventia Bio Inc. endo pharmaceutical SANOFI By types, the market can be split into Type
Published Date: Dec 2016
Published By: QYResearch

Price: $3500
EpiCast Report: Bladder Cancer - Epidemiology Forecast to 2025
Summary Bladder cancer is a commonly diagnosed cancer and causes significant numbers of cancer deaths worldwide. The major risk factors for bladder cancer are exposure to smoking and occupational risk factors such as exposure to aromatic amines. These risk factors are more prevalent among men, which makes the disease significantly more common in men than women. The majority of bladder cancer cases are among older individuals, with the median age at diagnosis being 73 years; because of this, the comorbidities associated with bladder cancer are similar to conditions typically occurring in older age, and therefore are not specific to bladder cancer. GlobalData epidemiologists forecast that by 2025, the 7MM are expected to have 289,623 diagnosed incident cases of bladder cancer, representing a
Published Date: Dec 2016
Published By: GlobalData

Price: $3995
Gallbladder Cancer - Pipeline Review, H2 2016
Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gallbladder Cancer – Pipeline Review, H2 2016, provides an overview of the Gallbladder Cancer (Oncology) pipeline landscape. Gallbladder cancer is a cancer that starts in the gallbladder. Symptoms include abdominal pain, nausea and/or vomiting, jaundice, loss of appetite, fever, itchy skin, dark urine and weight loss. Risk factors include overweight, age, family history, gallstones, gender and choledochal cysts. Treatment includes surgery, chemotherapy and radiation therapy. Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Gallbladder Cancer – Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for
Published Date: Nov 2016
Published By: Global Markets Direct

Price: $2000
Muscle Invasive Bladder Cancer (MIBC) - Pipeline Review, H2 2016
Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Muscle Invasive Bladder Cancer (MIBC) – Pipeline Review, H2 2016, provides an overview of the Muscle Invasive Bladder Cancer (MIBC) (Oncology) pipeline landscape. Muscle-invasive disease is a type of bladder cancer which is much more likely to spread to other parts of the body Symptoms includes blood in the urine and pain when passing urine. Risk factors include use of tobacco, family history, exposure to arsenic, and infections. Treatment includes removing the bladder or treating the bladder with radiation and chemotherapy. Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Muscle Invasive Bladder Cancer (MIBC) – Pipeline Review, H2 2016, provi
Published Date: Nov 2016
Published By: Global Markets Direct

Price: $2000
Bladder cancer - Epidemiology Forecast To 2023
Please note: This report requires 5-7 business days to complete. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication. Scope of the Report • The Report includes the prevalent population and how will it change over the next eight years. • Prevalent or incident cases segmented by age and sex. • Coverage of key Bladder cancer subpopulations and its prevalent or incident cases • The key differences in epidemiology patterns across the seven market segments Key Coverage and Benefits • The report will help in developing business strategies by understanding the trends shaping and driving the global Bladder cancer market. • Identifying prevalent patient populations as well as risk factors in the global Blad
Published Date: Nov 2016
Published By: DelveInsight

Price: $2750
Gallbladder Cancer  - Epidemiology Forecast To 2023
Please note: This report requires 5-7 business days to complete. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication. Scope of the Report • The Report includes the prevalent population and how will it change over the next eight years. • Prevalent or incident cases segmented by age and sex. • Coverage of key Gallbladder Cancer  subpopulations and its prevalent or incident cases • The key differences in epidemiology patterns across the seven market segments Key Coverage and Benefits • The report will help in developing business strategies by understanding the trends shaping and driving the global Gallbladder Cancer  market. • Identifying prevalent patient populations as well as risk factors in the
Published Date: Nov 2016
Published By: DelveInsight

Price: $2750
Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H2, 2016
Summary GlobalData's clinical trial report, “Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H2, 2016" provides an overview of Muscle Invasive Bladder Cancer (MIBC) clinical trials scenario. This report provides top line data relating to the clinical trials on Muscle Invasive Bladder Cancer (MIBC). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical t
Published Date: Oct 2016
Published By: GlobalData

Price: $2500
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2016
Summary Global Markets Direct’s, ‘Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2016’, provides an overview of the Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in the
Published Date: Sep 2016
Published By: Global Markets Direct

Price: $2000
Bladder cancer- Market Insights, Epidemiology and Market Forecast-2023
Note*: This report requires 7-10 business days to complete. DelveInsight’s Bladder cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Bladder cancer forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Bladder cancer till 2023. Key Coverage and Benefits • The report will help in developing business strategies by understanding the trends shaping and driving the global Bladder cancer market. •
Published Date: Aug 2016
Published By: DelveInsight

Price: $4950
United States Non Muscle Invasive Bladder Cancer Drugs Industry 2016 Market Research Report
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Non Muscle Invasive Bladder Cancer Drugs market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact inf
Published Date: Jul 2016
Published By: QYResearch

Price: $3800

Upcoming Reports

Wheelchair Accessible Vehicle Converters Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
Vehicles which are converted in a way that have easy access for wheelchairs are termed as wheelchair accessible vehicles or WAV’s. The vehicles are specially converted from a standard vehicle to WAV in order to accommodate the wheelchair. Wheelchair accessible vehicles are considered as mult
Published By: Transparency
Price: $5795
Enteral Nutrition Pumps Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
Enteral nutrition pumps also known as enteral feeding pumps are used to deliver nutritious foods containing carbohydrate, protein, fat, vitamin, minerals and water by inserting directly into the stomach or parts of small intestine. Enteral nutrition pumps are recommended to patients suffering from
Published By: Transparency
Price: $5795
Residential Water Treatment Equipment Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2014 - 2020
Increasing industrial and environmental pollution around the world is increasing the need for water treatment. Water pollution due to increasing industrialization and environment pollution is leading to death and spread of diseases. It also adversely affects more than 1 billion of population every
Published By: Transparency
Price: $5795
Steam Boiler System Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecast 2014 - 2020
The growing need of effective heating systems as well as the requirement of increasing operating efficiency of residential and commercial complexes has led to the widespread adoption of steam boiler systems. This technology provides high steam temperature and improved pressure parameters to achiev
Published By: Transparency
Price: $5795
Seismic Survey Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecast 2014 - 2020
Increasing exploration activities owing to the efforts of oil and gas companies to locate new oil and gas reserves is expected to drive the global seismic survey market during the forecast period. Oil and gas companies use seismic surveys to map and interpret potential petroleum reserves.  P
Published By: Transparency
Price: $5795

Back To Top